GENOTYPE-PHENOTYPE PITFALLS IN GAUCHER DISEASE

被引:13
作者
STRASBERG, PM
TRIGGSRAINE, BL
WARREN, IB
SKOMOROWSKI, MA
MCINNES, B
BECKER, LE
CALLAHAN, JW
CLARKE, JTR
机构
[1] HOSP SICK CHILDREN,DEPT GENET,DIV CLIN GENET,TORONTO M5G 1X8,ON,CANADA
[2] UNIV TORONTO,FAC MED,DEPT CLIN BIOCHEM,TORONTO,ON,CANADA
[3] MCGILL UNIV,MONTREAL CHILDRENS HOSP,RES INST,MONTREAL H3H 1P3,PQ,CANADA
[4] HOSP SICK CHILDREN,DEPT PATHOL,TORONTO M5G 1X8,ON,CANADA
[5] UNIV TORONTO,DEPT BIOCHEM,TORONTO,ON,CANADA
[6] UNIV TORONTO,DEPT MED GENET,TORONTO,ON,CANADA
关键词
NEURONOPATHIC; MUTATION; PCR; PSEUDOGENE; FUSION GENE;
D O I
10.1002/jcla.1860080409
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Gaucher disease (GD), caused by inherited deficiency of beta-glucocerebrosidase (beta-Glc, EC 3.1.2.45), is classified type I if the CNS is not involved (non-neuronopathic), type II if CNS involvement is early and rapidly progressive (acute neuronopathic), and type III if CNS involvement occurs later and is slowly progressive (subacute neuronopathic). The clinical course is not predictable by measurement of residual beta-Glc activity. Patient classification by identifcation of specific mutations is more promising: homozygosity for the common A(5841)->G (N370S) mutation invariably predicts type I; homozygosity for the T-6433->C (L444P) mutation usually indicates type III (Norbottnian). Type II disease patients often carry the T-6433->C allele together with a complex allele derived in part from the downstream pseudogene by crossover or gene conversion, producing a T-6433->C substitution, plus 2 or 3 additional single base substitutions (fusion gene). Employing selective PCR amplification of the
引用
收藏
页码:228 / 236
页数:9
相关论文
共 51 条
[1]   GENE CONVERSION - SOME IMPLICATIONS FOR IMMUNOGLOBULIN GENES [J].
BALTIMORE, D .
CELL, 1981, 24 (03) :592-594
[2]  
Barranger J. A., 1989, METABOLIC BASIS INHE
[3]  
BERGMANN JE, 1989, AM J HUM GENET, V44, P741
[4]   POLYMORPHISMS IN THE HUMAN GLUCOCEREBROSIDASE GENE [J].
BEUTLER, E ;
WEST, C ;
GELBART, T .
GENOMICS, 1992, 12 (04) :795-800
[5]   GAUCHER DISEASE - NEW MOLECULAR APPROACHES TO DIAGNOSIS AND TREATMENT [J].
BEUTLER, E .
SCIENCE, 1992, 256 (5058) :794-799
[6]   IDENTIFICATION OF THE 2ND COMMON JEWISH GAUCHER DISEASE MUTATION MAKES POSSIBLE POPULATION-BASED SCREENING FOR THE HETEROZYGOUS STATE [J].
BEUTLER, E ;
GELBART, T ;
KUHL, W ;
SORGE, J ;
WEST, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10544-10547
[7]  
BEUTLER E, 1993, AM J HUM GENET, V52, P85
[8]   GAUCHER DISEASE ASSOCIATED WITH A UNIQUE KPNI RESTRICTION SITE - IDENTIFICATION OF THE AMINO-ACID SUBSTITUTION [J].
BEUTLER, E ;
GELBART, T .
ANNALS OF HUMAN GENETICS, 1990, 54 :149-153
[9]   IDENTIFICATION OF 6 NEW GAUCHER DISEASE MUTATIONS [J].
BEUTLER, E ;
GELBART, T ;
WEST, C .
GENOMICS, 1993, 15 (01) :203-205
[10]   MOLECULAR ANALYSIS OF GAUCHER DISEASE - SCREENING OF PATIENTS IN THE MONTREAL QUEBEC REGION [J].
CHOY, FYM ;
WOO, M ;
DERKALOUSTIAN, VM .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1991, 41 (04) :469-474